An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Merck Sharp & Dohme LLC500 enrolled

Overview

The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

500

Conditions

Obesity

Interventions

MK0364DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who are obese (considerably overweight) based on body mass index. Exclusion Criteria: * Patients with serious or unstable current or past medical conditions

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.